HMOX1 and chronic thromboembolic pulmonary hypertension: To advance research in the drug treatment of CTEPH, our investigation has revealed the promising binding affinity of HMOX1-STANNSOPORFIN through targeted drug analysis and molecular docking studies.Notably, a study has demonstrated that STANNSOPORFIN effectively inhibits the proliferation and migration of the non-small cell lung cancer cell line A54938.